An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum
The 5th ProCAncer-I Consortium Meeting took place on the 07 – 08 November 2022, at ILO Campus, in Turin. The meeting was hybrid and more than 65 people attended the meeting. This was the first physical meeting where almost all partners were present, and we were glad to get to know each other. During the project, the progress and various issues for the implementation of the project were discussed
Prostate cancer can vary greatly in how aggressive it is, and knowing this in advance helps doctors decide the best course of treatment. Magnetic resonance imaging (MRI) is often used to detect prostate cancer, but figuring out just how aggressive the cancer is...
We are delighted to invite you to our session, “ProCAncer-I: An AI Platform Integrating Multiparametric MRI and AI Models”, at the European Congress of Radiology (ECR) 2025. Date: 26 February 2025 Time: 15:00 – 16:00 Location: ECR 2025, Vienna, Austria (conference...
ProCAncer-I will organise a Dedicated Session on the project during the European Congress of Radiology 2025 on the 26th of February 2025, at 15.00-16.00, with the title "ProCAncer-I: an AI platform integrating multiparametric MRI and AI models" where we will present...
Harnessing Big Data for the Future of Healthcare: Innovative Solutions with EUCAIM, ProCAncer-I, and European Health Data Spaces